Poor 'Health literacy' keeps patients from taking meds

Poor 'Health literacy' keeps patients from taking meds
In study, adults with diabetes who didn't grasp health info often skipped needed drugs.

(HealthDay)—Adult diabetes patients who don't understand basic health information are less likely to continue taking newly prescribed antidepressants, a new study finds.

This is an important issue because depression in adults with diabetes is often chronic and may require long-term treatment with medication, the researchers said.

The nearly 1,400 patients in the study were followed for 12 months after being prescribed an antidepressant. Most of the patients filled the prescription at least once, but 43 percent did not refill the prescription and nearly two-thirds had stopped taking their by the end of the study.

The investigators found that 72 percent of the patients struggled to understand basic health instructions, which the study authors called "limited ." These patients were much less likely to keep taking their than those with literacy, the authors said in a news release from Kaiser Permanente.

This difference was not explained by other factors known to be associated with patients not taking prescribed medications, including age, race and ethnicity, income, and level of English-language skills, according to the study, which was published in the March issue of the Journal of General Internal Medicine.

"The high rates of early discontinuation ... among adults with diabetes who had any health literacy limitation suggest that few of these individuals received an adequate course of antidepressant therapy," lead author Dr. Amy Bauer, of the University of Washington School of Medicine, said in the news release. "Getting that sufficient treatment is critical in preventing and recurrence of depression."

"Physicians should be aware of this," Bauer added. "For antidepressant treatment to succeed, patients with limited health literacy may require more intensive counseling and clearer explanations about use of antidepressant medications and closer follow-up."

Study senior author Andrew Karter, a research scientist at Kaiser Permanente, said other studies have found that "those with health literacy limitations are more likely to have poor control of their chronic medical conditions, such as diabetes, congestive heart failure and HIV."

He added, however, that "this is the first study to examine the association between health literacy and antidepressant adherence among patients with diabetes. This type of research gives our health care systems important feedback because, as providers, we often remain unsure whether the critical health information we convey to our patients is fully understood."

The researchers said the new findings highlight the importance of efforts to improve people's health literacy, simplify information about treatment options, improve public understanding about depression treatment, and monitor whether are taking their prescribed antidepressants.

More information: The U.S. National Institute of Mental Health has more about diabetes and depression.

add to favorites email to friend print save as pdf

Related Stories

A link between antidepressants and type 2 diabetes

Mar 25, 2008

While analyzing data from Saskatchewan health databases, Lauren Brown, researcher with the U of A’s School of Public Health, found people with a history of depression had a 30 per cent increased risk of type 2 Diabetes.

Online messaging delivers follow-up care for depression

Mar 16, 2011

Online messaging can deliver organized follow-up care for depression effectively and efficiently, according to a randomized controlled trial of 208 Group Health patients that the Journal of General Internal Medicine e-published in adv ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

User comments